Deals Report: GSK is latest pharma to draw on Flagship portfolio

Flagship entered a discovery deal with GSK to start the new week, while Day One and Dren Bio each forged deals with large pharmas that will add nine-figure sums to their balance sheets.

In the latest agreement between Flagship Pioneering and a pharma, GSK plc (LSE:GSK; NYSE:GSK) and the venture firm agreed to fund up to 10 exploratory projects that draw on the firm’s portfolio and the underlying platforms of its companies, aiming to develop new medicines. Initially, the partners will center their attention on treatments for respiratory and immunology disorders...